Skip to main content
. 2022 Jul 29;2022:2493053. doi: 10.1155/2022/2493053

Table 2.

Comparison of the changes of the NIHSS and mRS scores between 2 groups at admission and 3 months after stroke.

Variable ALC group (n = 34) Placebo group (n = 35) p value
Admission NIHSS score, mean ± SD 13.06 ± 3.70 12.26 ± 5.03 0.45

3-month after-stroke NIHSS score, mean ± SD 7.24 ± 4.39 9.60 ± 4.32 0.02

NIHSS alteration from admission to 3 months after stroke, mean ± SD −5.82 ± 4.51 −2.83 ± 3.08 0.002

Admission mRS score, mean ± SD 2.53 ± 0.78 2.51 ± 0.98 0.62

3-month after-stroke mRS score, mean ± SD 1.65 ± 1.6 2.54 ± 1.60 0.02

mRS alteration from baseline to 3 months after stroke, mean ± SD −0.94 ± 1.30 0.11 ± 1.34 0.002

Note: ALC = acetyl-L-carnitine; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin Scale. The significant p value is shown in bold type.